Back
to sessions
Sep 28
Scientific
SS 22 - Some crHEME with Your Coffee? A Winning Blend of Radiation and Systemic Therapy in Hematologic Malignancies
MODERATOR(S)
Michael Oertel, MD, PhD - University Hospital of Muenster
Susan Wu, MD - MD Anderson Cancer Center
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
10:45am - 10:55am ET
Clinical Factors Associated with Response to Low-Dose Total Skin Electron Beam Therapy: A Multi-Institutional Study By ILROG
Speaker: Jennifer Chiang, MD, MS - Stanford Health Care, Stanford -
10:55am - 11:05am ET
Tislelizumab plus P-GemOx-14 and Radiotherapy for Early-Stage High-Risk Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Phase 2 Trial
Speaker: Shunan Qi, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
11:05am - 11:15am ET
30Gy vs 40Gy Consolidative Radiotherapy for Limited-Stage Diffuse Large B cell Lymphoma Achieving Complete Remission after Chemotherapy: A Randomized, Open-Label, Non-Inferiority, Multicenter Phase 3 Clinical Trial
Speaker: Xin Liu, MD - State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PU, Beijing -
11:15am - 11:25am ET
Safety of Maintenance Pembrolizumab (Pembro) and Concurrent Radiotherapy (RT) in Pediatric Participants with Classic Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (Chemo): Post Hoc Analysis of the KEYNOTE-667 Study
Speaker: Bradford Hoppe, MD, FASTRO, MPH - Mayo Clinic Florida, Jacksonville -
11:25am - 11:35am ET
Patterns of Progression after BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Lesion-Level PET/CT Analysis
Speaker: Alexandra Dreyfuss, MD, MS - University of Miami - Sylvester Cancer Center, Coral Gables -
11:35am - 11:45am ET
Bridging Radiotherapy Reduces Systemic Inflammation Prior to CAR T-Cell Therapy for B-Cell Lymphomas
Speaker: Brandon Imber, MD, MS - Memorial Sloan Kettering Cancer Center, New York -
11:45am - 11:55am ET
a and ß Emitting Radiopharmaceutical Therapy (RPT) and Total Marrow and Lymphoid Irradiation (TMLI) Conditioning in Relapsed / Refractory (R/R) AML / ALL Undergoing Allogeneic Transplant (alloHCT)
Speaker: Jeffrey Wong, MD, FASTRO - City of Hope National Medical Center, Duarte